← The Wire
GKOSNYSE
GLAUKOS Corp
Surgical & Medical Instruments & Apparatus · DE · CIK 1192448
Develops and commercializes novel ophthalmic therapies and medical technologies for eye diseases
$7.45B
Market cap
$142.19
Last close
-1.5%
1D
+8.4%
5D
1.2M
Volume
Price · last 39 sessions+4.7%
May 4L $103.12 · H $144.42Jun 29
245
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
SC 13GSC 13GDec 11, 2023SC 13GSC 13GJan 31, 2023SC 13GSCHEDULE 13GFeb 10, 2022SC 13GSEC SCHEDULE 13GJan 10, 2022SC 13GGLAUKOS CORPFeb 10, 2021SC 13GSCHEDULE 13GFeb 14, 2020SC 13GSC 13GJan 22, 2020SC 13GSC 13GFeb 14, 2019SC 13GSC 13GFeb 13, 2019SC 13GSC 13GJan 10, 2019SC 13GSC 13GFeb 14, 2018SC 13GSC 13GFeb 8, 2018SC 13GSC 13GFeb 1, 2018SC 13GJANUS HENDERSON GROUP PLC OWNS 11.8% OF GKOSNov 13, 2017SC 13GSC 13GSep 25, 2017SC 13GSC 13GFeb 14, 2017SC 13GSC 13GFeb 13, 2017SC 13GSC 13GFeb 22, 2016SC 13GSC 13GFeb 16, 2016SC 13GSC 13GFeb 16, 2016SC 13GSC 13GFeb 16, 2016SC 13GSCHEDULE 13GFeb 12, 2016SC 13GSC 13GFeb 12, 2016SC 13GSC 13GFeb 10, 2016SC 13GSCHEDULE 13G FOR GLAUKOS CORPORATIONJan 19, 2016
Insider Activity
In the 90 days to Mar 25, 2026: 6 sold $37.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 2026 | Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER | Sell | 2,511 | $106.46 | $267K |
| Mar 24, 2026 | Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER | Sell | 1,521 | $105.24 | $160K |
| Mar 17, 2026 | Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER | Sell | 625 | $99.15 | $62K |
| Mar 16, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Sell | 460 | $97.33 | $45K |
| Mar 16, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Sell | 299 | $98.21 | $29K |
| Mar 16, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Sell | 272 | $99.05 | $27K |
| Feb 19, 2026 | Weisner Aimee SDirector | Sell | 6,471 | $118.56 | $767K |
| Feb 19, 2026 | Weisner Aimee SDirector | Sell | 5,242 | $116.64 | $611K |
| Feb 19, 2026 | Weisner Aimee SDirector | Sell | 2,153 | $115.69 | $249K |
| Feb 19, 2026 | Weisner Aimee SDirector | Sell | 1,134 | $117.33 | $133K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 4,325 | $129.11 | $558K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 3,892 | $126.96 | $494K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 3,812 | $126.07 | $481K |
| Jan 22, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 3,194 | $129.28 | $413K |
| Jan 22, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 3,100 | $127.03 | $394K |
| Jan 22, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 2,406 | $126.10 | $303K |
| Jan 22, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 1,798 | $128.07 | $230K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 1,671 | $127.92 | $214K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 1,300 | $129.78 | $169K |
| Jan 21, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 4,502 | $124.65 | $561K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance